PRKN and amyotrophic lateral sclerosis: Thus, chronic PARKIN expression in ALS may lead to sustained activation of mitochondrial quality control leading to a depletion of mitochondrial dynamic-related proteins and inhibition of mitochondrial biogenesis, and these alterations ultimately lead to progressive mitochondrial dysfunction [47].